Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
J Hand Surg Am ; 48(9): 953.e1-953.e9, 2023 09.
Article in English | MEDLINE | ID: mdl-35525682

ABSTRACT

PURPOSE: As the duration of lifetime survival after organ transplantation continues to increase, the consequences of long-term immunosuppression, such as opportunistic and rare infections, are a high-risk reality. This study examined upper extremity infections in the transplant population to determine the current clinical risk profile, management, and outcomes. METHODS: An institutional database of 16,640 patients who underwent transplantation was queried for upper extremity infections from 2005 to 2017, defined as the presence of infection from the shoulder to the fingertips. The resulting data were analyzed using multivariable linear and logistic regression modeling. RESULTS: A total of 230 eligible patients experienced upper extremity infections at a mean age of 54.1 ± 15.3 years, occurring, on average, 7.9 ± 8.6 years after transplantation. The most commonly transplanted organ was the kidney (51.3%), followed by the liver (20%). The most common location of infection was the forearm (31.7%), digits (27.4%), and upper arm (17%). The most common types of infection were cellulitis (69.1%), abscess (33.5%), joint sepsis (6.5%), infectious tenosynovitis (3.9%), and osteomyelitis (1.3%). Patients taking an antifungal medication, those who had a joint infection, or those who had undergone lung transplantation had an approximately 2.5-day longer stay in the hospital. For every 1-year increase in age at the time of transplantation, the time from transplantation to infection decreased by 0.21 years. Those who had undergone bone marrow transplantation or those who were taking tacrolimus were expected to have approximately 8- and 6-year decreases, respectively, in the time from transplantation to infection. CONCLUSIONS: Upper extremity infections should be individually evaluated and treated because of the heterogeneity of transplant type, immunosuppression medications, the age of the patient, and infection characteristics. TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic IV.


Subject(s)
Organ Transplantation , Upper Extremity , Humans , Adult , Middle Aged , Aged , Infant , Upper Extremity/surgery , Upper Extremity/microbiology , Tacrolimus/therapeutic use , Organ Transplantation/adverse effects , Arm , Forearm
2.
J Hand Surg Am ; 48(11): 1159.e1-1159.e10, 2023 11.
Article in English | MEDLINE | ID: mdl-35637039

ABSTRACT

PURPOSE: We analyzed patient demographic factors involved in the development of nonmarinum, nontuberculous mycobacterial infections (NTMI) involving the upper extremity, and assessed diagnostic and prognostic values of commonly used preoperative laboratory and imaging studies, as well as factors related to recurrence of disease and patient outcomes. METHODS: Patients from 2 academic, tertiary facilities with culture-proven, nonmarinum NTMI involving the upper extremity were reviewed. Patient-related factors and clinical outcomes were extracted. The analysis was based on pathogen identification (rapid- vs slow-growing subspecies) and immune status. RESULTS: Our 76 patients had a mean age of 59 years, and 65% were male. Forty-eight percent reported an injury, and hands were frequently involved (58%). Forty-one percent were immunosuppressed (19% organ transplant recipients). The mean symptom duration prior to presentation was 203 days. The culture identification took a mean of 33 days, with 25 different species identified (subcategorized as rapid or slow growers). Seventy-seven percent had solitary lesions, with a cutaneous or subcutaneous location most common. Immunosuppressed patients were treated longer with antibiotics (243 vs 155 days in immunocompetent patients) and experienced higher rates of side effects, complications, and recurrence. All patients underwent debridement to control infection, including 4 individuals who required amputations. One-third experienced complications and/or recurrence, regardless of the organism type. CONCLUSIONS: Upper-extremity nonmarinum NTMI is often misdiagnosed, causing management delays. Early consideration in differential diagnoses of chronic, painful swelling, nodular or inflammatory lesions, or septic arthritis is crucial. Tissue biopsy with specimens for histopathology and microbiological analysis (mycobacterial smear, cultures, and broad range polymerase chain reaction) and early involvement with an infectious disease specialist are recommended. Empiric antibiotic therapy is not standard. Debridement and prolonged, directed combination antimicrobial therapy is required; however, adverse reactions are commonly encountered. TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic IV.


Subject(s)
Arthritis, Infectious , Upper Extremity , Humans , Male , Middle Aged , Female , Upper Extremity/microbiology , Hand , Combined Modality Therapy , Arthritis, Infectious/therapy , Diagnostic Imaging , Anti-Bacterial Agents/therapeutic use , Retrospective Studies
3.
J Hand Surg Am ; 43(1): 68-74, 2018 01.
Article in English | MEDLINE | ID: mdl-29174095

ABSTRACT

Implant related infection is relatively unusual in surgery to the hand and distal upper limb. When such infections occur, the consequences can be devastating. We review the latest guidance and research on the prevention, diagnosis, and management of implant-associated infections in the hand and distal upper limb.


Subject(s)
Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/therapy , Upper Extremity/microbiology , Upper Extremity/surgery , Anti-Infective Agents/therapeutic use , Biofilms , Debridement , Humans , Reoperation , Risk Factors
4.
J Hand Surg Am ; 43(4): 387.e1-387.e8, 2018 04.
Article in English | MEDLINE | ID: mdl-29223631

ABSTRACT

PURPOSE: To present our experience with culture-positive, nontuberculous mycobacterial infections (NTMI) of the upper extremity and to compare the clinical features and outcomes of treatment among immunocompetent and immunocompromised patients. METHODS: All patients at our medical center diagnosed with NTMI of the upper extremity from December 1, 2000, through December 31, 2015, were included. We performed a retrospective analysis of patient demographic characteristics, delay to diagnosis, risk factors, clinical presentation, specific location, diagnostic testing, treatment regimens, and outcomes. These variables were compared between immunocompetent and immunocompromised patients. RESULTS: Forty-four patients were identified with culture-positive NTMI of the upper extremity. Of the patients, 27 (61%) were men (median age, 59 years [range, 23-83 years]). Twenty (45%) patients were immunocompromised. Immunocompromised patients had fewer known inoculation injuries compared with immunocompetent patients (45% vs 92%). A significant difference existed in the treatment regimens selected for immunocompetent versus immunocompromised patients: immunocompetent patients were more often treated with both antibiotics and surgery (88% vs 50%), whereas immunocompromised patients were more often treated with antibiotics alone (45% vs 4%). Overall, 24% experienced treatment failure and 9% died. Outcomes were relatively similar between immunocompetent and immunocompromised patients. A shorter delay to diagnosis was associated with a lower failure rate. CONCLUSIONS: Diagnosis of upper-extremity NTMI is often delayed because of indolent presentation and lack of clinical suspicion. The clinical presentation, diagnostic delay, and diagnostic testing results are similar between immunocompetent and immunocompromised patients. Although treatment varied significantly between patient groups, outcomes were similar. Timely diagnosis has the greatest impact on patient outcome. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic IV.


Subject(s)
Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/therapy , Upper Extremity/microbiology , Adult , Age Distribution , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/epidemiology , Arthritis, Infectious/microbiology , Arthritis, Infectious/therapy , Debridement , Delayed Diagnosis , Drainage , Female , Florida/epidemiology , Granuloma/diagnostic imaging , Granuloma/microbiology , Humans , Immunocompromised Host , Male , Middle Aged , Mycobacterium Infections, Nontuberculous/epidemiology , Osteomyelitis/epidemiology , Osteomyelitis/microbiology , Osteomyelitis/therapy , Retrospective Studies , Risk Factors , Sex Distribution , Synovectomy , Tenosynovitis/epidemiology , Tenosynovitis/microbiology , Tenosynovitis/therapy , Tertiary Care Centers , Upper Extremity/surgery , Young Adult
5.
J Hand Surg Am ; 42(2): e77-e89, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28011032

ABSTRACT

PURPOSE: Fungal infections involving the tenosynovium of the upper extremity are uncommon and are often misdiagnosed. This study evaluates the epidemiology, diagnosis, treatment, and outcomes of patients with fungal tenosynovitis of the upper extremity over a 20-year period. METHODS: A retrospective review of all culture-confirmed cases of fungal tenosynovitis of the upper extremity treated between 1990 and 2013 at a single institution was performed. Clinical data included patient and epidemiologic risk factors, causative fungal organism, surgical management, antimicrobial regimen, recurrence rates, and outcomes. RESULTS: There were 10 patients (9 female, 1 male) who met the inclusion criteria. The mean patient age was 60 years (range, 47-76 y). Identified pathogens included Histoplasmacapsulatum (7), Coccidioides posadasii/immitis (2), and Cryptococcus neoformans (1). Eight patients were on immunosuppressant medications at the time of diagnosis. The most common clinical presentation was subacute localized pain, swelling, and erythema consistent with tenosynovitis. The diagnosis was delayed by a median of 6 months (range, 0-48 mo). The most helpful diagnostic imaging studies included magnetic resonance imaging and ultrasound. All patients were treated with extensive surgical synovectomy and debridement. Seven patients were treated by a single surgery, whereas 3 required multiple consecutive debridements (2, 7, and 10 surgeries). The mean course of initial antimicrobial therapy was 8.2 months (range, 3-12 mo). Clinical recurrence was noted in 3 patients (30%) during a median follow-up period of 46 months (range, 7-250 mo). Both patients with Coccidioides infection incurred recurrence. CONCLUSIONS: Although uncommon, surgeons and clinicians should consider a diagnosis of fungal tenosynovitis among immunocompromised patients with signs of mild tenosynovitis and should consider operative debridement and biopsy. Although the majority of patients were successfully treated with surgical debridement and antimicrobial therapy, a recurrence rate of 30% highlights the need for close post-treatment follow-up. TYPE OF STUDY/LEVEL OF EVIDENCE: Therapeutic V.


Subject(s)
Mycoses/diagnosis , Mycoses/microbiology , Mycoses/therapy , Tenosynovitis/diagnosis , Tenosynovitis/microbiology , Tenosynovitis/therapy , Upper Extremity/microbiology , Aged , Antifungal Agents/therapeutic use , Combined Modality Therapy , Debridement , Diagnostic Imaging , Female , Humans , Immunocompromised Host , Male , Middle Aged , Retrospective Studies , Treatment Outcome
6.
Klin Khir ; (4): 50-3, 2016 Apr.
Article in Ukrainian | MEDLINE | ID: mdl-27434956

ABSTRACT

Abstract Results of bacteriological investigations of a gun-shot and a mine-explosion woundings of the extremities were analyzed in Military-Medical Clinical Centres (MMCC) of Kyiv, Lviv and Vinnytsya. Spectrum of the allotted microorganisms and profile of their antibioticoresistance were disclosed. The patterns of resistance were determined in accordance to offering of international experts of European Committee on Antimicrobial Susceptibility Testing (EUCAST). Dominating microflora in a Chief MMCC (Kyiv) and MMCC of a Western Region (Lviv) were various species of the Enterobacteriaceae and P. aeruginosa families, while in MMCC of a Central Region (Vinnytsya)--a gramm-negative non-fermentative bacilli of the Acinetobacter genus and Pseudomonas genus. The majority (79.5%) of isolates were characterized by polyresistance for antibiotics. Maximal quantity of strains with a widened spectrum of resistance was revealed in 2 - 3 weeks after a wounding--in 71.4 and 96.9% accordingly.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Multiple, Bacterial , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Anti-Bacterial Agents/classification , Blast Injuries/drug therapy , Blast Injuries/microbiology , Blast Injuries/surgery , Explosions , Gram-Negative Bacteria/growth & development , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/surgery , Gram-Positive Bacteria/growth & development , Gram-Positive Bacteria/isolation & purification , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/surgery , Humans , Lower Extremity/microbiology , Lower Extremity/surgery , Microbial Sensitivity Tests , Retrospective Studies , Ukraine , Upper Extremity/microbiology , Upper Extremity/surgery , Wounds, Gunshot/drug therapy , Wounds, Gunshot/microbiology , Wounds, Gunshot/surgery
7.
Rehabil Nurs ; 40(5): 310-9, 2015.
Article in English | MEDLINE | ID: mdl-25042377

ABSTRACT

PURPOSE: This study aimed to examine factors associated with reported infection and symptoms among individuals with extremity lymphedema. DESIGN: A cross-sectional study was used. METHODS: Data were collected from a survey supported by the National Lymphedema Network from March 2006 through January 2010. A total of 1837 participants reported having extremity lymphedema. Logistic regression analyses were used. FINDINGS: Factors associated with reported infection among individuals with extremity lymphedema included male gender, decreased annual household income, decreased self-care, self-report of heaviness, and lower extremity as opposed to upper extremity. Factors associated with symptoms included infection, decreased self-care, lower knowledge level of self-care, decreased annual household income, and presence of secondary lower extremity lymphedema. CONCLUSIONS/CLINICAL RELEVANCE: Select factors of income, self-care status, and site of lymphedema were associated with increased occurrence of infection and symptoms among individuals with extremity lymphedema. Longitudinal studies are needed to identify risk factors contributing to infections and symptoms in individuals with lymphedema.


Subject(s)
Infections/epidemiology , Infections/rehabilitation , Lymphedema/epidemiology , Lymphedema/rehabilitation , Rehabilitation Nursing/methods , Self Care/methods , Cohort Studies , Comorbidity , Cross-Sectional Studies , Female , Humans , Lower Extremity/microbiology , Lower Extremity/physiopathology , Lymphedema/nursing , Male , Risk Factors , Sex Factors , Socioeconomic Factors , United States/epidemiology , Upper Extremity/microbiology , Upper Extremity/physiopathology
8.
Hand Surg Rehabil ; 43(3): 101718, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38782364

ABSTRACT

OBJECTIVES: Necrotizing soft-tissue infection and necrotizing fasciitis of the upper limb are infrequent. Studies are rare, and often include other anatomical regions. The specificities and particularities of this pathology are not well known. The aim of this study was to report diagnosis and treatment aspects. METHODS: A retrospective study was conducted over 10 years on every patient treated for necrotizing fasciitis of the upper limb with clinical, bacteriological and histological confirmation. One hundred ninety-eight items were extracted for each patient concerning clinical, biological, radiological and therapeutic data. RESULTS: During 10 years, 24 patients were diagnosed with necrotizing fasciitis of the upper limb: 18 males, 6 females; mean age, 59.9 years; mean body mass index, 25. Local erythema, pain and fever were the most frequent symptoms. Skin necrosis was present in fewer than 40% of patients. Sixteen cases (66.6%) had prior skin lesions and/or an entry point on the limb. Ten had non-steroidal anti-inflammatory drug prescription before acute symptom onset (42%), requiring intensive care unit admission. Treatment comprised surgical resection, resuscitative measures, antibiotic therapy and reconstructive surgery. Seven patients (30.4%) had 1 session of cutaneous excision, and the others had more than 2. Microbiological analysis found mono-microbial beta-hemolytic group A streptococci (BHGAS) infection in 14 patients (58.4%). Antibiotics were prescribed in 91% of cases before surgery, and in 100% after. The most frequently prescribed substance was clindamycin (18 patients, 75%). Ten patients (42%) stayed in the intensive care unit during treatment. Seventeen patients (70.8%) had thin skin graft reconstruction, including 50% with dermal substitute. Five patients (20.8%) had partial upper limb amputation. Two patients (8.3%) died in the 30 days following diagnosis. CONCLUSIONS: The death rate in necrotizing fasciitis of the upper limb was rather low but the amputation rate was higher than in other locations. This study shows the specific clinical, biological and treatment features of this rare but serious pathology of the upper limb.


Subject(s)
Anti-Bacterial Agents , Fasciitis, Necrotizing , Upper Extremity , Humans , Male , Fasciitis, Necrotizing/microbiology , Fasciitis, Necrotizing/therapy , Fasciitis, Necrotizing/surgery , Middle Aged , Female , Retrospective Studies , Aged , Upper Extremity/surgery , Upper Extremity/microbiology , Adult , Anti-Bacterial Agents/therapeutic use , Debridement , Soft Tissue Infections/microbiology , Soft Tissue Infections/therapy , Aged, 80 and over , Streptococcal Infections/microbiology , Streptococcal Infections/therapy
10.
J Assoc Physicians India ; 60: 89-93, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22715553

ABSTRACT

BACKGROUND: Anthrax is a life-threatening infectious disease that normally affects animals, especially ruminants. It is caused by the bacteria Bacillus anthracis. The most common mode of infection is through the skin, which causes a painless sore that usually heals without treatment. If left untreated, cutaneous anthrax may progress in up to 20% of cases to septicaemia with potentially lethal outcome. METHODOLOGY: We visited a small tribal village of the state of West Bengal, where an outbreak of cutaneous anthrax was suspected following slaughtering a dead bullock. The population at risk were subjected to detailed interrogation, thorough clinical examination and relevant investigations. RESULTS: The mean age of our study population was 32.1 years, and 100% were male. The mean incubation period was three days. Most cases (81.8%) were exposed to the bacteria during butchering. The predominantly affected sites were fingers (54.5%), followed by forearms (18.2%), around elbows (18.2%) and arm (9.1%). All cases initially had painless papules, ulcers with vesicles; dissemination of the lesion was seen in 27.3% of patients. 9 patients (who were alive) underwent complete blood count, baseline biochemistry and chest X-ray. Smears were made from the cutaneous lesions for gram's stain in 5 patients. Wound swabs were also inoculated in nutrient broth and subcultured in blood agar media. FNAC from the enlarged axillary lymph node was done in 1 patient and blood was sent for aerobic culture in 2 individuals. Both the blood cultures were sterile. Smears made from the culture obtained from cutaneous lesion of one of the affected person revealed gram positive aerobic spore bearing non-motile bacilli in long chain with capsular halo suggesting Bacillus anthracis. In this outbreak, the attack rate was 7% and case fatality rate was 18%. CONCLUSION: Cutaneous anthrax should be considered as a differential diagnosis in cases presenting with painless ulcers, vesicles or eschars with a recent history of exposure to animals or animal products. It is important to recognise the clinical aspects of this disease in routine practice since any delay in treatment may have fatal consequences, as observed in this study.


Subject(s)
Anthrax/epidemiology , Bacillus anthracis/isolation & purification , Disease Outbreaks , Skin Diseases, Bacterial/epidemiology , Adolescent , Adult , Animals , Anthrax/diagnosis , Anthrax/drug therapy , Anthrax/microbiology , Anti-Bacterial Agents/therapeutic use , Contact Tracing , Epidemiologic Studies , Humans , Incidence , India/epidemiology , Male , Middle Aged , Population Surveillance , Risk Factors , Rural Population , Severity of Illness Index , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/microbiology , Treatment Outcome , Upper Extremity/microbiology , Young Adult
11.
Afr J Med Med Sci ; 40(2): 159-62, 2011 Jun.
Article in English | MEDLINE | ID: mdl-22195385

ABSTRACT

Sixty-eight (68) patients with serious upper extremity suppurative infections, presenting within a period of fifteen (15) months, were prospectively studied clinically, Gram stain of aspirates/pus were performed, specimen cultured, planted, and where indicated glucose levels and haemoglobin genotype determined. Half of the patients had hand infections. Staphylococcus aureus was isolated from thirty-nine (39) patients. Gram Negative bacilli, including Salmonella were more isolated from patients with diabetes mellitus or Hgb SS or SC. The Gram stain results correlated with the culture result 90%. When Gram Positive cocci were demonstrated in the primary microscopic examination, cultures were not mandatory. When no organism was demonstrated on primary Gram stain or the patient was diabetic or a sickler, cultures of the specimens were done. The Gram stain, well performed, remains a useful, inexpensive, technologically appropriate laboratory test for abetting decision making in patients with upper extremity suppurative infections. Organisms encountered in this study included: Staphylococcus aureus, Streptococcus pyogenes, Salmonella typhi, Proteus mirabilis, Pseudomonas aeruginosa, and Coliforms.


Subject(s)
Gentian Violet , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Cocci/isolation & purification , Phenazines , Suppuration/microbiology , Adult , Anti-Bacterial Agents/therapeutic use , Emergency Service, Hospital , Female , Gram-Negative Bacteria/classification , Gram-Negative Bacteria/drug effects , Gram-Negative Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Cocci/classification , Gram-Positive Cocci/drug effects , Hospitals, Religious , Humans , Male , Microbial Sensitivity Tests , Nigeria , Prospective Studies , Staining and Labeling , Suppuration/drug therapy , Upper Extremity/microbiology
13.
Diabetes Metab Syndr ; 14(5): 1071-1075, 2020.
Article in English | MEDLINE | ID: mdl-32650278

ABSTRACT

BACKGROUND: Necrotizing soft tissue infection (NSTI) of the upper extremities is a rare, but potentially life-threatening infection in patients with type 2 diabetes mellitus (T2DM). We analyzed the clinical characteristics and the outcome of NSTI of upper extremities in these patients. METHODS: This was a retrospective study analyzing the clinical characteristics and the outcomes of 33 T2DM patients with NSTI of upper extremities, who were treated in the department of hand surgery between January 2011 and December 2017. RESULTS: Predisposing factors for NSTI were recognized in 16 (48.5%) patients. Eleven (33.3)% patients had septic shock while ten (30.3%) had acute renal insufficiency at the time of presentation, of which six required dialysis. The mean glycosylated hemoglobin was 9.6(±2.6)% and the random plasma glucose at admission was 271(±96) mg/dl. Monomicrobial infection was seen in 16(49%) patients and polymicrobial infection in 9(27%) patients. Gram-positive causation was found in 25(66%) patients. Twelve (36.4%) patients required amputation, six (18.2%) of which were major. Death occurred in more than one-fifth (21.2%) of the patients during treatment. CONCLUSION: Necrotizing soft tissue infection of the upper extremities in T2DM is associated with increased risk of severe infection, amputation and mortality.


Subject(s)
Diabetes Mellitus, Type 2/complications , Hospitalization/statistics & numerical data , Soft Tissue Infections/pathology , Tertiary Care Centers/statistics & numerical data , Upper Extremity/microbiology , Blood Glucose/analysis , Female , Follow-Up Studies , Humans , India/epidemiology , Male , Middle Aged , Necrosis , Prognosis , Retrospective Studies , Risk Factors , Soft Tissue Infections/epidemiology , Soft Tissue Infections/microbiology
14.
Hand (N Y) ; 15(1): 45-53, 2020 01.
Article in English | MEDLINE | ID: mdl-30035635

ABSTRACT

Background: Immunosuppression is encountered in patients with oncologic, transplant, and autoimmune disorders. The purpose of this study is to provide guidance for physicians treating surgical hand and upper extremity (UE) infections in immunosuppressed (IS) patients. Methods: We retrospectively reviewed our database of patients presenting with UE infections over 3 years. IS patients were matched randomly to non-IS patients. Patient background, infection presentation, surgical evaluation, and microbiology variables were recorded. Infection variables included mechanism, location, and type. Outcomes included inpatient length of stay (LOS) and need for repeat drainage. Results: We identified 35 IS and 35 non-IS out of 409 UE infection patients. Patients most commonly had a hematologic malignancy (34%) as their IS class, and the most frequent immunosuppressive medication was glucocorticoids (57%). IS patients were more likely to be older and less likely to have a history of drug abuse or hepatitis C virus infections. IS infections were more likely to have idiopathic mechanisms, more likely to involve deeper anatomy such as joints, bone, tendon sheath, or muscle/fascia, and less likely to present with leukocytosis. IS cultures more commonly exhibited atypical Mycoplasma or fungus. There was no difference between IS and non-IS patients regarding LOS or recurrent drainage. Conclusions: Mechanism and white blood cell count are less reliable markers of infection severity in IS patients. Physicians treating infections in IS patients should maintain a higher suspicion for deeper involved anatomy and atypical microbiology. Nonetheless, with careful inpatient management and closer surveillance, outcomes in IS patients can approach that of non-IS patients.


Subject(s)
Immunocompromised Host/immunology , Immunosuppression Therapy/adverse effects , Orthopedic Procedures/adverse effects , Surgical Wound Infection/immunology , Upper Extremity/surgery , Adult , Aged , Case-Control Studies , Databases, Factual , Drainage/statistics & numerical data , Female , Humans , Length of Stay/statistics & numerical data , Leukocyte Count , Male , Middle Aged , Orthopedic Procedures/standards , Orthopedic Surgeons/standards , Practice Guidelines as Topic , Retrospective Studies , Surgical Wound Infection/diagnosis , Surgical Wound Infection/therapy , Treatment Outcome , Upper Extremity/microbiology
15.
Mycoses ; 52(4): 339-42, 2009 Jul.
Article in English | MEDLINE | ID: mdl-18793263

ABSTRACT

Outbreaks of Trichophyton tonsurans infection constitute one of the serious problems among combat sports practitioners in Japan. To facilitate the diagnosis of individuals at risk, we undertook a study to determine which body sites are most commonly infected. We reviewed medical data, hairbrush culture results and questionnaire information from patients with T. tonsurans infection who were admitted to the dermatology clinic of Juntendo University hospital from 2000 to 2004. The study included 92 patients (87 males), aged 6-38 years (mean age: 18.4 years old). Eighty-nine patients were judo practitioners and three were wrestlers. Twenty-eight patients (30.4%) were asymptomatic carriers. In 64 patients, 51 patients (55.4%) with tinea corporis, 27 patients (29.3%) with tinea capitis, and/or one patient (1.1%) with tinea manuum were seen. Tinea corporis was observed on the forehead, auricles, nape of the neck, bilateral shoulders, left side of the upper chest, both elbows, back of the left hand to the wrist and both knees. Tinea capitis was most common in the occipitonuchal region at the hairline and in the temporal and frontal regions, at both auricles. Initial screening of these sites might facilitate the identification of the infection especially in judo practitioners.


Subject(s)
Athletes/statistics & numerical data , Tinea/epidemiology , Tinea/microbiology , Trichophyton/isolation & purification , Adolescent , Adult , Child , Female , Humans , Japan/epidemiology , Knee/microbiology , Male , Martial Arts/statistics & numerical data , Retrospective Studies , Trichophyton/genetics , Trichophyton/physiology , Upper Extremity/microbiology , Wrestling/statistics & numerical data , Young Adult
16.
Ann Dermatol Venereol ; 136(1): 9-14, 2009 Jan.
Article in French | MEDLINE | ID: mdl-19171223

ABSTRACT

BACKGROUND: Anthrax is an acute infection caused by the Gram-positive organism, Bacillus anthracis, which rarely affects humans under normal conditions. Depending on the mode of contamination, there are three distinct clinical forms: pulmonary, gastrointestinal and cutaneous. This type of infection is still common in the developing countries, a fact that should be borne in mind by examining doctors, and in particular by dermatologists. It is important to recognise the clinical aspects of this disease rarely encountered in clinical practice since any delay in treatment may have fatal consequences, as illustrated by our case reports. CASE REPORTS: Five men and two women of mean age 35years presented one or more cutaneous lesions of the upper limbs in all instances. All patients had a fever of 39-40 degrees C but none were presenting gastrointestinal or pulmonary signs. Neurological signs and/or disturbed consciousness were seen in three patients. Bacteriological diagnosis was based on isolation of B. anthracis in cultures of skin specimens. Treatment with parenteral or oral ciprofloxacin was initiated in six patients, and this therapy was combined with oral corticosteroids in three patients. A favourable outcome was achieved in four patients, while the remaining three patients died of their disease. DISCUSSION: Anthrax is an anthropozoonosis that has now become rare in the developed countries. The disease is contracted by humans through touching either animals killed by anthrax or the products thereof. The cases we report were subsequent to collective contamination of several members of a single family, probably due to contact with goats carrying the disease. If left untreated, cutaneous anthrax may progress in 5 to 20% of cases to septicaemia with potentially lethal central nervous system involvement. The only means of eradicating anthrax in animals, and thus in humans, is through animal vaccination.


Subject(s)
Anthrax/diagnosis , Skin Diseases, Bacterial/diagnosis , Adolescent , Adult , Animals , Anthrax/drug therapy , Anthrax/transmission , Anti-Infective Agents/therapeutic use , Ciprofloxacin/therapeutic use , Female , Humans , Male , Middle Aged , Skin Diseases, Bacterial/drug therapy , Upper Extremity/microbiology , Young Adult , Zoonoses
17.
J Hand Surg Asian Pac Vol ; 24(2): 189-194, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31035876

ABSTRACT

Background: Hand and upper limb soft tissue infections result in significant disability and loss of productivity. Many infections have been shown to follow a seasonal variation, however little is known about this is the context of upper limb soft tissue infections. We aimed to evaluate seasonal variation in acute bacterial, hand and upper limb skin and soft-tissue infections, and correlate findings with key environmental variables. Methods: Hand and upper limb soft tissue infection cases from 2006-2016 were retrieved from a single UK center. Cases were reviewed for microbiology culture and sensitivity. Correlation between cases and season, temperature and humidity was assessed. Results: 206 cases were identified for inclusion. Specimens were sent for microbiology in 76.4% of cases. Of these 78.9% were culture positive, 47.6% exhibited antibiotic resistance and 16.9% were multi-resistant. There was a significant difference between season and culture positive cases, with significantly more culture positive cases in the summer vs. winter on post-hoc analysis (p = 0.004). There was a significant positive correlation between higher temperatures and number of culture positive cases (r = 0.75). There was no significant correlation between temperature and antibiotic resistance (r = 0.5) or between humidity and culture positive cases (r = -0.42). Conclusions: This study demonstrates a seasonal variation in hand and upper limb infections, with a significant correlation between infection rates and ambient temperature. Appreciating seasonal variability of these infections could prove beneficial for surgical planning, public health recommendations and antibiotic guidelines. However, further international data is needed to understand potential mechanisms involved.


Subject(s)
Hand/microbiology , Seasons , Soft Tissue Infections/epidemiology , Upper Extremity/microbiology , Humans , Humidity , Retrospective Studies , Soft Tissue Infections/microbiology , Temperature , United Kingdom/epidemiology
18.
J Hand Surg Asian Pac Vol ; 24(2): 129-137, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31035877

ABSTRACT

Background: Community Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA) rates have been increasing worldwide and contribute to a growing "global health security threat" as reported by the WHO. Our group previously reported an overall rate of 7% in CA-MRSA upper extremity infections between 2004-2009 at the Auckland Regional Hand Unit. This fell below the Center for Disease Control (CDC) recommendation for empiric antimicrobial cover once local rates exceed 10-15%. We examined prevalence and characteristics of CA-MRSA upper extremity infections in our region over a subsequent 5-year period. Methods: One thousand two hundred and fifty-two patients with upper extremity infections requiring operative management between 2011 and 2015 inclusive were included in this study. Associated clinical characteristics were recorded including ethnicity, cultured organisms, antibiotic sensitivities, infection rate, and treatment practice. Results: One hundred and fifty (12%) of patients had culture positive CA-MRSA upper extremity infections. There was an increasing annual trend. Of note, rates of CA-MRSA in the Maori and Pacific Island ethnic subpopulations exceeded 15% in 2014 and 2015. Susceptibilities, associated factors and patient demographics are reported. Conclusions: Our unit enjoys significantly lower rates of CA-MRSA upper extremity infections than has been reported internationally. However, trends are increasing relative to our prior 6-year report, and the threshold for empiric treatment has been met within the Maori and Pacific Island ethnic subpopulations. This evolving threat is also highlighted by increasing cases of multi-drug resistant CA-MRSA. Evolving regional guidelines for empiric coverage of CA-MRSA among high-risk ethnic subpopulations identified by this study are underway.


Subject(s)
Community-Acquired Infections/epidemiology , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/epidemiology , Upper Extremity/microbiology , Adult , Arthritis, Infectious/epidemiology , Arthritis, Infectious/microbiology , Community-Acquired Infections/microbiology , Female , Humans , Male , Native Hawaiian or Other Pacific Islander , New Zealand/epidemiology , Prevalence , Skin Diseases, Infectious/epidemiology , Skin Diseases, Infectious/microbiology , Soft Tissue Infections/epidemiology , Soft Tissue Infections/microbiology
19.
Med Sci Monit ; 14(10): CR511-4, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18830190

ABSTRACT

BACKGROUND: All Staphylococcus aureus isolated during 2003-2006 at a university hospital in Thessalia, central Greece, from ulcerative upper-extremity infections were tested for the presence of PVL gene and for possible clonal relationship to validate the role of PVL toxin in the clinical features of these infections and also to establish preventive measures towards limiting the spread of such strains among close contacts. MATERIAL/METHODS: Of 305 bacterial cultures obtained from consecutive patients suffering from purulent musculoskeletal infections of an upper extremity, 207 revealed the presence of S. aureus (81 methicillin-resistant and 126 methicillin-sensitive). Seventy of the 207 cultures were found to be positive for the PVL gene. RESULTS: The PVL gene was detected in 12.1% (2003), 46.7% (2004), 34% (2005), and 53% (2006) of upper-extremity staphylococcal infections, indicating a statistically significant increase between 2003 and 2004-2006. However, there was a significant decrease in readmissions during 2005 and 2006 and also in the number of relatives diagnosed with PVL-positive infections during the same period of time. The localization of these infections, their higher incidence during summer, and the transmission to family members indicated that contact was the means of spread of PVL-positive S. aureus. Most isolates belonged to the ST-80 clone, predominant in Europe. CONCLUSIONS: The emergence of new MRSA and also MSSA clones carrying the PVL gene and the decreases in readmissions and number of infected "close contacts" emphasizes the need for closer systematic surveillance and the implementation of preventive measures.


Subject(s)
Bacterial Toxins/genetics , Exotoxins/genetics , Leukocidins/genetics , Methicillin-Resistant Staphylococcus aureus/genetics , Staphylococcal Infections , Staphylococcus aureus/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Drug Resistance, Bacterial , Female , Greece , Humans , Male , Methicillin-Resistant Staphylococcus aureus/pathogenicity , Microbial Sensitivity Tests , Middle Aged , Staphylococcal Infections/epidemiology , Staphylococcal Infections/pathology , Staphylococcus aureus/pathogenicity , Upper Extremity/microbiology , Upper Extremity/pathology , Young Adult
20.
Article in English | MEDLINE | ID: mdl-18470793

ABSTRACT

Group A beta-haemolytic streptococcus is a well-known cause of necrotising fasciitis, which is increasing in incidence and severity. More aggressive soft tissue infections of the hand and upper extremity caused by this organism have been noted in our plastic surgical unit, prompting a five-year retrospective study to find out which factors affect clinical outcomes. The records of 31 patients, 27 male and 4 female, with Group A beta-haemolytic streptococcal soft tissue infections with a mean (SD) age of 25 (12) years were reviewed. Twenty-seven infections followed injuries, while four were spontaneous. Six patients required more than two operations to clear the infection, and one required free tissue transfer for closure of the resulting soft tissue deficit. Of the variables age, number of cigarettes consumed daily, interval from the date of injury to the date of presentation, coexisting infection with Staphylococcus aureus, and grade of infection at presentation, only the last correlated with the patients' clinical course (p<0.001). Those patients with spontaneous infections with pre-existing medical conditions had a worse prognosis, requiring more operations and a longer stay in hospital. A multicentre prospective study would be useful to confirm these findings.


Subject(s)
Fasciitis, Necrotizing/epidemiology , Streptococcal Infections/epidemiology , Streptococcus pyogenes , Upper Extremity/microbiology , Adolescent , Adult , Age Factors , Child , Child, Preschool , Comorbidity , Fasciitis, Necrotizing/microbiology , Female , Hand/microbiology , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Severity of Illness Index , Smoking/epidemiology , Soft Tissue Infections/epidemiology , Soft Tissue Infections/microbiology , Staphylococcal Infections/epidemiology , Streptococcal Infections/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL